Literature DB >> 2313402

Pap tests of rural black women.

J A Sawyer1, J Earp, R H Fletcher, F F Daye, T M Wynn.   

Abstract

Cervical cancer is an important cause of cancer mortality in black women. Pap tests may prevent such deaths, but poor, rural black women are relatively less likely than others to be screened. In order to understand why that is so, the authors surveyed 149 women in three rural North Carolina counties. Thirty-three percent of the women interviewed had not had a Pap test in the preceding three years. Variables independently associated with not having a recent Pap test included: having no identifiable source of medical care; having more than one source of gynecologic care; having an internist provide gynecologic care; and perceiving psychological barriers to Pap tests and pelvic examinations. Income, educational level, and health insurance status were not associated with having a recent Pap test. Although access to care remains a problem for some, better use should be made of the medical care encounters available.

Entities:  

Mesh:

Year:  1990        PMID: 2313402     DOI: 10.1007/bf02600510

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  15 in total

1.  Who gets screened for cervical and breast cancer? Results from a new national survey.

Authors:  R A Hayward; M F Shapiro; H E Freeman; C R Corey
Journal:  Arch Intern Med       Date:  1988-05

2.  Characteristics of blacks obtaining Papanicolaou smears.

Authors:  R B Warnecke; S Graham
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

3.  Reverse targeting of preventive care due to lack of health insurance.

Authors:  S Woolhandler; D U Himmelstein
Journal:  JAMA       Date:  1988-05-20       Impact factor: 56.272

4.  Social contact factors in the diffusion of cervical cytology among Mexican-Americans in Los Angeles County, California.

Authors:  J W McCurtis
Journal:  Soc Sci Med Med Psychol Med Sociol       Date:  1979-11

5.  National trends in the use of preventive health care by women.

Authors:  D M Makuc; V M Freid; J C Kleinman
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

6.  Attendance for cervical screening--whose problem?

Authors:  A Eardley; A K Elkind; B Spencer; P Hobbs; L L Pendleton; D Haran
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

7.  Missed opportunities for early diagnosis of cancer of the cervix.

Authors:  R G Fruchter; J Boyce; M Hunt
Journal:  Am J Public Health       Date:  1980-04       Impact factor: 9.308

8.  A comparison of physician and patient reports of Pap smear histories.

Authors:  S D Walter; E A Clarke; J Hatcher; L W Stitt
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

Review 9.  Socioeconomic status and survival for breast and cervical cancer.

Authors:  D P Funch
Journal:  Women Health       Date:  1986 Fall-Winter

10.  Cervical cancer screening practices among older women: results from the Maryland Cervical Cancer Case-Control Study.

Authors:  D D Celentano; A C Klassen; C S Weisman; N B Rosenshein
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

View more
  5 in total

1.  Cervical cancer: screening hard-to-reach groups.

Authors:  E Grunfeld
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

2.  The health status of African-American elderly.

Authors:  M A Bernard
Journal:  J Natl Med Assoc       Date:  1993-07       Impact factor: 1.798

3.  Hyperinsulinemia and acanthosis nigricans in African Americans.

Authors:  C A Stuart; C R Gilkison; B S Keenan; M Nagamani
Journal:  J Natl Med Assoc       Date:  1997-08       Impact factor: 1.798

4.  Income, race, and mortality.

Authors:  T Sterling; W Rosenbaum; J Weinkam
Journal:  J Natl Med Assoc       Date:  1993-12       Impact factor: 1.798

5.  Cancer prevention behaviors among African-American adults: a survey of wards 7 and 8 in Washington, DC.

Authors:  S Shankar; V Y Kofie; K Helzlsouer; M L Rivo; G Bonney
Journal:  J Natl Med Assoc       Date:  1995-01       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.